A DNA-Based MRI Contrast Agent for Quantitative pH Measurement
- PMID: 33625209
- PMCID: PMC9489053
- DOI: 10.1021/acssensors.1c00296
A DNA-Based MRI Contrast Agent for Quantitative pH Measurement
Abstract
Extracellular pH is important in clinical measurements due to its correlation to cell metabolism and disease progression. In MRI, T1/T2 ratiometric analysis and other methods have been previously applied to quantify pH using conventional pulse sequences. However, for nanoparticle-based approaches, heterogeneity in size and surface functionalization tends toward qualitative rather than quantitative results. To address this limitation, we developed a novel DNA-based MRI contrast agent, pH-DMRCA, which utilizes a highly programmable and reproducible nanostructure. The pH-DMRCA is a dendritic DNA scaffold that is functionalized with a pH-responsive MRI-sensitive construct, Gd(NP-DO3A), at the end of each DNA arm. We first evaluated the r1 and r2 response of our pH-DMRCA over a range of pH values (pH = 5-9) to establish a relaxometric model of pH. These MRI-based assessments of pH were validated in a separate set of samples using a pH electrode (n = 18) and resulted in a good linear correlation (R2 = 0.99, slope = 0.98, intercept = 0). A Bland-Altman analysis of the results also showed reasonable agreement between the calculated pH and measured pH. Moreover, these pH comparisons were consistent across three different pH-DMRCA concentrations, demonstrating concentration-independence of the method. This MRI-based pH quantification methodology was further verified in human blood plasma. Given the versatility of the DNA-based nanostructures, the contrast agent has a potential to be applied to a wide variety of imaging applications where extracellular pH is important including cancer, stroke, cardiovascular disease, and other important diseases.
Keywords: DNA dendrimer; DNA nanostructure; MRI contrast agent; bioimaging; pH quantification.
Figures



Similar articles
-
Concentration-independent MRI of pH with a dendrimer-based pH-responsive nanoprobe.Contrast Media Mol Imaging. 2015 Nov-Dec;10(6):481-6. doi: 10.1002/cmmi.1651. Epub 2015 Jul 14. Contrast Media Mol Imaging. 2015. PMID: 26173742 Free PMC article.
-
Ratiometric MRI sensors based on core-shell nanoparticles for quantitative pH imaging.Adv Mater. 2014 May 21;26(19):2989-92. doi: 10.1002/adma.201305018. Epub 2014 Jan 22. Adv Mater. 2014. PMID: 24453039
-
Estimation of Gadolinium-based Contrast Agent Concentration Using Quantitative Synthetic MRI and Its Application to Brain Metastases: A Feasibility Study.Magn Reson Med Sci. 2019 Oct 15;18(4):260-264. doi: 10.2463/mrms.mp.2018-0119. Epub 2019 Feb 19. Magn Reson Med Sci. 2019. PMID: 30787250 Free PMC article.
-
Rational Design of Magnetic Nanoparticles as T1-T2 Dual-Mode MRI Contrast Agents.Molecules. 2024 Mar 18;29(6):1352. doi: 10.3390/molecules29061352. Molecules. 2024. PMID: 38542988 Free PMC article. Review.
-
Surface impact on nanoparticle-based magnetic resonance imaging contrast agents.Theranostics. 2018 Apr 3;8(9):2521-2548. doi: 10.7150/thno.23789. eCollection 2018. Theranostics. 2018. PMID: 29721097 Free PMC article. Review.
Cited by
-
pH-responsive i-motif-conjugated nanoparticles for MRI analysis.Sens Diagn. 2024 Mar 6;3(4):623-630. doi: 10.1039/d3sd00285c. eCollection 2024 Apr 18. Sens Diagn. 2024. PMID: 38646186 Free PMC article.
-
Fast quantitative MRI: Spiral Acquisition Matching-Based Algorithm (SAMBA) for Robust T1 and T2 Mapping.J Magn Reson Open. 2024 Sep;20:100157. doi: 10.1016/j.jmro.2024.100157. Epub 2024 Jul 29. J Magn Reson Open. 2024. PMID: 39324129 Free PMC article.
References
-
- Carr DH; Brown J; Bydder GM; Steiner RE; Weinmann HJ; Speck U; Hall AS; Young IR Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. AJR, Am. J. Roentgenol 1984, 143, 215–224. - PubMed
-
- Runge VM; Clanton JA; Lukehart CM; Partain CL; James AE Paramagnetic agents for contrast-enhanced NMR imaging: a review. AJR, Am. J. Roentgenol 1983, 141, 1209–1215. - PubMed
-
- Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E Pushing the Sensitivity Envelope of Lanthanide-Based Magnetic Resonance Imaging (MRI) Contrast Agents for Molecular Imaging Applications. Acc. Chem. Res 2009, 42, 822–831. - PubMed
-
- Angelovski G What We Can Really Do with Bioresponsive MRI Contrast Agents. Angew. Chem., Int. Ed 2016, 55, 7038–7046. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous